Finance

Lists
OSE:EPA
Ose Immunotherapeutics SA
€2.75
-4.78%
(-0.14) 1D
Sep 10, 5:35:11 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
€2.89
High
€2.96
Low
€2.75
Mkt. cap
68.51M
Avg. vol.
137.68K
Volume
159.22K
52-wk high
€7.70
52-wk low
€2.75
EPS
-€1.69
Shares outstanding
23.56M
No. of employees
64
Open
€2.89
High
€2.96
Low
€2.75
Mkt. cap
68.51M
Avg. vol.
137.68K
Volume
159.22K
52-wk high
€7.70
52-wk low
€2.75
EPS
-€1.69
Shares outstanding
23.56M
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
FoundedNov 17, 2004
Headquarters-
SectorBiotechnology
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2024
Sep 2024
Dec 2024
Revenue
41.29M
431.00K
431.00K
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
6.94M
8.28M
8.28M
Total research and development expenses
-
-
-
Selling, general, and admin expenses
2.05M
1.08M
1.08M
Operating expense
9.63M
10.22M
10.22M
Total operating expenses
9.63M
10.22M
10.22M
Operating income
31.66M
-9.79M
-9.79M
Other non operating income
-596.00K
-611.00K
-611.00K
EBT including unusual items
30.36M
-10.44M
-10.44M
EBT excluding unusual items
30.33M
-10.53M
-10.53M
Income tax expense
1.77M
-576.50K
-576.50K
Effective tax rate
5.83%
5.52%
5.52%
Other operating expenses
94.50K
41.00K
41.00K
Net income
28.59M
-9.86M
-9.86M
Net profit margin
69.24%
-2,288.86%
-2,288.86%
Earnings per share
-
-
-
Interest and investment income
162.50K
571.00K
571.00K
Interest expense
-878.50K
-707.50K
-707.50K
Net interest expenses
-716.00K
-136.50K
-136.50K
Depreciation and amortization charges
-
-
-
EBITDA
31.72M
-9.74M
-9.74M
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps